Regeneron Pharmaceuticals, Inc. nyheder

REGNSeneste aktienyheder og analyser

Piper Sandler Adjusts Price Target on Regeneron Pharmaceuticals to $854 From $855

MT Newswires·-29696844851 min. siden

Is Regeneron Pharmaceuticals, Inc. (REGN) Stock Still a Biotech Leader After Analyst Price Target Cut?

Insider Monkey·-29695640268 min. siden

Morgan Stanley Adjusts Price Target Regeneron Pharmaceuticals to $730 From $788, Maintains Equalweight Rating

MT Newswires·-29695323184 min. siden

Will Regeneron (REGN) Beat Estimates Again in Its Next Earnings Report?

Zacks·-29694280251 min. siden

Biopharma Sector Seen Shifting to Fundamentals From Macro in H2, Morgan Stanley Says

MT Newswires·-29695662001 min. siden

MAIA Biotechnology Says Ateganosine Shows 90.5% Disease Control Rate in Phase 2 Expansion Trial

MT Newswires·-29695622984 min. siden

Collect 9.0% On VRTX Stock Now, And Still Keep 15% Of Upside

Trefis·-29695518651 min. siden

Truist Securities Adjusts Regeneron Pharmaceuticals Price Target to $769 From $778

MT Newswires·-29694084034 min. siden

RBC Capital Adjusts Regeneron Pharmaceuticals Price Target to $696 From $707, Maintains Sector Perform Rating

MT Newswires·-29693999484 min. siden

Jim Cramer Calls Biotech “The Hottest Group in the Market” as He Predicts “Deals Are Going to Be Flooding the Market”

24/7 Wall St.·-29694300451 min. siden

Nyheder leveret af Yahoo Finance. Reportly er ikke ansvarlig for indholdet af eksterne artikler. Ikke en handelsanbefaling.